Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)
 
Authors :  S. J. F. Macdonald, M. D. Dowle, L. A. Harrison, G. D. E. Clarke, G. G. A. Inglis, M. R. Johnson, R. A. Smith, A. Amour, G. Fleetwood, D. C. Humphreys, C. R. Molloy, M. Dixon, R. E. Godward, A. J. Wonacott, O. M. P. Singh, S. T. Hodgson, G. W. Hardy
Date :  05 Jul 02  (Deposition) - 29 Aug 02  (Release) - 14 Sep 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.00
Chains :  Asym./Biol. Unit :  A,B
Keywords :  Hydrolase, Serine Protease, (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. J. F. Macdonald, M. D. Dowle, L. A. Harrison, G. D. E. Clarke, G. G. A. Inglis, M. R. Johnson, P. Shah, R. A. Smith, A. Amour, G. Fleetwood, D. C. Humphreys, C. R. Molloy, M. Dixon, R. E. Godward, A. J. Wonacott, O. M. P. Singh, S. T. Hodgson, G. W. Hardy
Discovery Of Further Pyrrolidine Trans-Lactams As Inhibitors Of Human Neutrophil Elastase (Hne) With Potential As Development Candidates And The Crystal Structure Of Hne Complexed With An Inhibitor (Gw475151)
J. Med. Chem. V. 45 3878 2002
PubMed-ID: 12190311  |  Reference-DOI: 10.1021/JM020881F

(-) Compounds

Molecule 1 - LEUKOCYTE ELASTASE
    CellLEUKOCYTE
    ChainsA, B
    EC Number3.4.21.37
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymELASTASE, NEUTROPHIL ELASTASE, PMN ELASTASE, BONE MARROW SERINE PROTEASE, MEDULLASIN

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 10)

Asymmetric/Biological Unit (3, 10)
No.NameCountTypeFull Name
11512Ligand/Ion(2S)-3-METHYL-2-((2R,3S)-3-[(METHYLSULFONYL)AMINO]-1-{[2-(PYRROLIDIN-1-YLMETHYL)-1,3-OXAZOL-4-YL]CARBONYL}PYRROLIDIN-2-YL)BUTANOICACID
2FUC4Ligand/IonALPHA-L-FUCOSE
3NAG4Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (6, 6)

Asymmetric Unit (6, 6)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHIS A:57 , LEU A:99B , ARG A:147 , ASN A:148 , ARG A:149 , CYS A:191 , PHE A:192 , GLY A:193 , SER A:195 , SER A:214 , PHE A:215 , VAL A:216 , HOH A:2015 , HOH A:2106 , HOH A:2134 , HOH A:2136BINDING SITE FOR RESIDUE 151 A 400
2AC2SOFTWARELEU B:99B , CYS B:191 , PHE B:192 , GLY B:193 , SER B:195 , SER B:214 , PHE B:215 , VAL B:216 , HOH B:2105BINDING SITE FOR RESIDUE 151 B 400
3AC3SOFTWAREARG A:63 , VAL A:65 , ARG A:65A , ASN A:109 , HOH A:2137BINDING SITE FOR CHAIN A OF SUGAR BOUND TO ASN A 109 RESIDUES 411 TO 412
4AC4SOFTWAREGLN A:135 , ASN A:159 , VAL A:200 , CYS A:201 , ASN A:204 , GLY A:205BINDING SITE FOR CHAIN A OF SUGAR BOUND TO ASN A 159 RESIDUES 401 TO 402
5AC5SOFTWAREARG B:65A , ALA B:84 , ASN B:109 , HOH B:2106BINDING SITE FOR CHAIN B OF SUGAR BOUND TO ASN B 109 RESIDUES 411 TO 412
6AC6SOFTWAREARG B:20 , TRP B:27 , GLN B:135 , ASN B:159 , VAL B:200 , CYS B:201 , ASN B:204 , GLY B:205BINDING SITE FOR CHAIN B OF SUGAR BOUND TO ASN B 159 RESIDUES 401 TO 402

(-) SS Bonds  (8, 8)

Asymmetric/Biological Unit
No.Residues
1A:42 -A:58
2A:136 -A:201
3A:168 -A:182
4A:191 -A:220
5B:42 -B:58
6B:136 -B:201
7B:168 -B:182
8B:191 -B:220

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 1H1B)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (85, 170)

Asymmetric/Biological Unit (85, 170)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_070696P42LELNE_HUMANDisease (SCN1)  ---A/BP28L
02UniProtVAR_070697F43LELNE_HUMANDisease (SCN1)  ---A/BF29L
03UniProtVAR_070698M44RELNE_HUMANDisease (SCN1)  ---A/BM30R
04UniProtVAR_070699V45EELNE_HUMANDisease (SCN1)  ---A/BV31E
05UniProtVAR_070700V45LELNE_HUMANDisease (CH)  ---A/BV31L
06UniProtVAR_070701S46CELNE_HUMANDisease (SCN1)  ---A/BS32C
07UniProtVAR_070702S46FELNE_HUMANDisease (SCN1)  ---A/BS32F
08UniProtVAR_070703L47PELNE_HUMANDisease (SCN1)878855319A/BL33P
09UniProtVAR_070704L47RELNE_HUMANDisease (SCN1)  ---A/BL33R
10UniProtVAR_070705L49PELNE_HUMANDisease (SCN1)  ---A/BL35P
11UniProtVAR_070706H53LELNE_HUMANDisease (SCN1)  ---A/BH40L
12UniProtVAR_070707H53QELNE_HUMANDisease (CH)  ---A/BH40Q
13UniProtVAR_070708H53YELNE_HUMANDisease (SCN1)  ---A/BH40Y
14UniProtVAR_070709C55SELNE_HUMANDisease (SCN1)  ---A/BC42S
15UniProtVAR_038609C55YELNE_HUMANDisease (SCN1)  ---A/BC42Y
16UniProtVAR_070710G56RELNE_HUMANDisease (SCN1)  ---A/BG43R
17UniProtVAR_070711A57SELNE_HUMANDisease (SCN1)  ---A/BA44S
18UniProtVAR_038610A57TELNE_HUMANDisease (SCN1)  ---A/BA44T
19UniProtVAR_070712A57VELNE_HUMANDisease (SCN1)  ---A/BA44V
20UniProtVAR_070713L59PELNE_HUMANDisease (SCN1)  ---A/BL46P
21UniProtVAR_038611I60TELNE_HUMANDisease (SCN1)  ---A/BI47T
22UniProtVAR_070715A61VELNE_HUMANDisease (SCN1)137854447A/BA48V
23UniProtVAR_070718S67WELNE_HUMANDisease (SCN1)  ---A/BS54W
24UniProtVAR_070719C71FELNE_HUMANDisease (SCN1)878855315A/BC58F
25UniProtVAR_038612C71RELNE_HUMANDisease (SCN1)28931611A/BC58R
26UniProtVAR_038613C71SELNE_HUMANDisease (SCN1)  ---A/BC58S
27UniProtVAR_070720C71YELNE_HUMANDisease (SCN1)  ---A/BC58Y
28UniProtVAR_070721V72GELNE_HUMANDisease (SCN1)  ---A/BV59G
29UniProtVAR_070722V80GELNE_HUMANDisease (SCN1)  ---A/BV65G
30UniProtVAR_070724V82MELNE_HUMANDisease (SCN1)  ---A/BV66M
31UniProtVAR_070725L84PELNE_HUMANDisease (SCN1)  ---A/BL68P
32UniProtVAR_038614G85EELNE_HUMANDisease (SCN1)  ---A/BG69E
33UniProtVAR_070726G85RELNE_HUMANDisease (SCN1)  ---A/BG69R
34UniProtVAR_070727Q97LELNE_HUMANDisease (CH)  ---A/BQ81L
35UniProtVAR_038615V98LELNE_HUMANDisease (SCN1)267606781A/BV82L
36UniProtVAR_070728V98MELNE_HUMANDisease (SCN1)  ---A/BV82M
37UniProtVAR_038616V101LELNE_HUMANDisease (SCN1)137854449A/BV85L
38UniProtVAR_038617V101MELNE_HUMANDisease (SCN1)28929494A/BV85M
39UniProtVAR_070729R103LELNE_HUMANDisease (SCN1)  ---A/BR87L
40UniProtVAR_070730R103PELNE_HUMANDisease (SCN1)  ---A/BR87P
41UniProtVAR_070731I104NELNE_HUMANDisease (CH)  ---A/BI88N
42UniProtVAR_070732I118VELNE_HUMANPolymorphism  ---A/BI103V
43UniProtVAR_070733I120FELNE_HUMANDisease (SCN1)  ---A/BI105F
44UniProtVAR_070734I120NELNE_HUMANDisease (SCN1)  ---A/BI105N
45UniProtVAR_070735I120SELNE_HUMANDisease (SCN1)  ---A/BI105S
46UniProtVAR_070736L121PELNE_HUMANDisease (SCN1)  ---A/BL106P
47UniProtVAR_070737L123HELNE_HUMANDisease (SCN1)  ---A/BL108H
48UniProtVAR_070738N124IELNE_HUMANDisease (SCN1)  ---A/BN109I
49UniProtVAR_070739G125RELNE_HUMANPolymorphism377698556A/BG110R
50UniProtVAR_038619S126LELNE_HUMANDisease (SCN1)137854450A/BS111L
51UniProtVAR_070740A127DELNE_HUMANDisease (SCN1)  ---A/BA112D
52UniProtVAR_070741A127PELNE_HUMANDisease (SCN1)  ---A/BA112P
53UniProtVAR_070742A131TELNE_HUMANUnclassified (SCN1)201729066A/BA116T
54UniProtVAR_070743V135MELNE_HUMANPolymorphism774457980A/BV120M
55UniProtVAR_070744A136DELNE_HUMANDisease (SCN1)  ---A/BA121D
56UniProtVAR_038620P139LELNE_HUMANDisease (SCN1)28929493A/BP124L
57UniProtVAR_070745P139RELNE_HUMANDisease (SCN1)  ---A/BP124R
58UniProtVAR_070746R143HELNE_HUMANUnclassified (CH)200993994A/BR128H
59UniProtVAR_070747C151FELNE_HUMANDisease (SCN1)  ---A/BC136F
60UniProtVAR_038621C151SELNE_HUMANDisease (SCN1)  ---A/BC136S
61UniProtVAR_070748C151WELNE_HUMANDisease (SCN1)  ---A/BC136W
62UniProtVAR_070749C151YELNE_HUMANUnclassified (SCN1)57246956A/BC136Y
63UniProtVAR_070750L152PELNE_HUMANDisease (SCN1)  ---A/BL137P
64UniProtVAR_070751A153DELNE_HUMANDisease (SCN1)  ---A/BA138D
65UniProtVAR_070752A153PELNE_HUMANDisease (SCN1)  ---A/BA138P
66UniProtVAR_070753W156CELNE_HUMANDisease (SCN1)  ---A/BW141C
67UniProtVAR_070754W156RELNE_HUMANDisease (SCN1)  ---A/BW141R
68UniProtVAR_064513A166TELNE_HUMANDisease (SCN1)201788817A/BA152T
69UniProtVAR_070755G203CELNE_HUMANDisease (SCN1)  ---A/BG196C
70UniProtVAR_070756G203RELNE_HUMANDisease (SCN1)  ---A/BG196R
71UniProtVAR_038623P205RELNE_HUMANDisease (SCN1)  ---A/BP198R
72UniProtVAR_070757L206FELNE_HUMANDisease (CH)137854446A/BL199F
73UniProtVAR_070758L206SELNE_HUMANDisease (SCN1)  ---A/BL199S
74UniProtVAR_070759C208GELNE_HUMANDisease (SCN1)  ---A/BC201G
75UniProtVAR_070760N209IELNE_HUMANDisease (CH)  ---A/BN204I
76UniProtVAR_038624G210VELNE_HUMANDisease (SCN1)  ---A/BG205V
77UniProtVAR_070761G210WELNE_HUMANDisease (CH)  ---A/BG205W
78UniProtVAR_070762G214EELNE_HUMANDisease (SCN1)  ---A/BG211E
79UniProtVAR_038625G214RELNE_HUMANDisease (SCN1)137854451A/BG211R
80UniProtVAR_019237V219IELNE_HUMANUnclassified (SCN1)17216656A/BV216I
81UniProtVAR_070764A233PELNE_HUMANDisease (SCN1)  ---A/BA229P
82UniProtVAR_070765V235EELNE_HUMANDisease (SCN1)  ---A/BV231E
83UniProtVAR_070766V235GELNE_HUMANDisease (SCN1)  ---A/BV231G
84UniProtVAR_070723R81PELNE_HUMANDisease (SCN1)  ---A/BR65AP
85UniProtVAR_070763R220QELNE_HUMANDisease (SCN1)137854445A/BR217AQ

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (3, 6)

Asymmetric/Biological Unit (3, 6)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TRYPSIN_DOMPS50240 Serine proteases, trypsin domain profile.ELNE_HUMAN30-247
 
  2A:16-243
B:16-243
2TRYPSIN_HISPS00134 Serine proteases, trypsin family, histidine active site.ELNE_HUMAN66-71
 
  2A:53-58
B:53-58
3TRYPSIN_SERPS00135 Serine proteases, trypsin family, serine active site.ELNE_HUMAN196-207
 
  2A:189-200
B:189-200

(-) Exons   (4, 8)

Asymmetric/Biological Unit (4, 8)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000002636211ENSE00000892229chr19:852291-852395105ELNE_HUMAN1-23230--
1.2ENST000002636212ENSE00000768824chr19:852876-853032157ELNE_HUMAN23-75532A:16-62 (gaps)
B:16-62 (gaps)
47
47
1.3ENST000002636213ENSE00000768826chr19:853262-853403142ELNE_HUMAN75-122482A:62-107 (gaps)
B:62-107 (gaps)
51
51
1.4ENST000002636214ENSE00000768828chr19:855564-855794231ELNE_HUMAN123-199772A:108-192 (gaps)
B:108-192 (gaps)
87
87
1.5ENST000002636215ENSE00000892230chr19:855958-856242285ELNE_HUMAN200-267682A:193-243 (gaps)
B:193-243 (gaps)
52
52

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:218
 aligned with ELNE_HUMAN | P08246 from UniProtKB/Swiss-Prot  Length:267

    Alignment length:218
                                    39        49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239        
          ELNE_HUMAN     30 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ  247
               SCOP domains d1h1ba_ A: Elastase                                                                                                                                                                                                        SCOP domains
               CATH domains 1h1bA01     1h1bA02 A:28-120,A:233-243 Trypsin-like serine proteases                                      1h1bA01 A:16-27,A:121-232 Trypsin-like serine proteases                                              1h1bA02     CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....ee........eeeeee..eeeeeeeeee..eeeehhhhhhh.hhh......................eeeeeeeee.........eeeee..........................eeeeee..............eeeeeee.........eeee...............eeee..eeeeeeee...........eeeee...hhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) ------------LLRECP-P---L-SRS-PTV-----W---FG-------GPM-PE-----------LL--L-LN-------------V-FP-HIRLD---T---MD--L---H-------FPD--C---------T------------------------------------C-RF-GIV---E----IQ------------P-E------------ SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------LFR-----Q-Y-T-------------R-------------R------------M--M-P----------------N------P-----------R-----------S-P--R----------------------------------------------R--S---W---R--------------------G------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------Y---V-------------S------------------------------------------------S------------------------------W------------------------------------------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------------------------Y-------------------------------------------------------------------------------Y------------------------------------------------------------------------------------------------ SAPs(SNPs) (4)
                PROSITE (1) TRYPSIN_DOM  PDB: A:16-243 UniProt: 30-247                                                                                                                                                                                 PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI----------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ---------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.2  PDB: A:16-62 (gaps) UniProt: 23-75  -----------------------------------------------Exon 1.4  PDB: A:108-192 (gaps) UniProt: 123-199                             Exon 1.5  PDB: A:193-243 (gaps) UniProt: 200-267 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------Exon 1.3  PDB: A:62-107 (gaps) UniProt: 75-122  ----------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                1h1b A   16 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ  243
                                    25        35||      46        56      ||64 |      73        83        94|| ||  104       114       124       134       144||     155    || 166 ||    184  |  | 192       204||     216|     |225       235        
                                               36|                      62A| 65A                         92||| ||                                           145|          160|   168|      186A  |          201|||     217A  222A                     
                                                38                       62B                              94|| ||                                            147           162    177         188A           204||                                    
                                                                                                           95| ||                                                                                             205|                                    
                                                                                                            98 ||                                                                                              208                                    
                                                                                                             99A|                                                                                                                                     
                                                                                                              99B                                                                                                                                     

Chain B from PDB  Type:PROTEIN  Length:218
 aligned with ELNE_HUMAN | P08246 from UniProtKB/Swiss-Prot  Length:267

    Alignment length:218
                                    39        49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239        
          ELNE_HUMAN     30 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ  247
               SCOP domains d1h1bb_ B: Elastase                                                                                                                                                                                                        SCOP domains
               CATH domains 1h1bB01     1h1bB02 B:28-120,B:233-243 Trypsin-like serine proteases                                      1h1bB01 B:16-27,B:121-232 Trypsin-like serine proteases                                              1h1bB02     CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....ee........eeeeee..eeeeeeeeee..eeeehhhhhh..hhhh.eeee............eeeeeeeeeeeee.........eeeee..........................eeeeee..............eeeeeeee........eeee...............eeee..eeeeeeee...........eeeee...hhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) ------------LLRECP-P---L-SRS-PTV-----W---FG-------GPM-PE-----------LL--L-LN-------------V-FP-HIRLD---T---MD--L---H-------FPD--C---------T------------------------------------C-RF-GIV---E----IQ------------P-E------------ SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------LFR-----Q-Y-T-------------R-------------R------------M--M-P----------------N------P-----------R-----------S-P--R----------------------------------------------R--S---W---R--------------------G------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------Y---V-------------S------------------------------------------------S------------------------------W------------------------------------------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------------------------Y-------------------------------------------------------------------------------Y------------------------------------------------------------------------------------------------ SAPs(SNPs) (4)
                PROSITE (1) TRYPSIN_DOM  PDB: B:16-243 UniProt: 30-247                                                                                                                                                                                 PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI----------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ---------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.2  PDB: B:16-62 (gaps) UniProt: 23-75  -----------------------------------------------Exon 1.4  PDB: B:108-192 (gaps) UniProt: 123-199                             Exon 1.5  PDB: B:193-243 (gaps) UniProt: 200-267 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------Exon 1.3  PDB: B:62-107 (gaps) UniProt: 75-122  ----------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                1h1b B   16 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ  243
                                    25        35||      46        56      ||64 |      73        83        94|| ||  104       114       124       134       144||     155    || 166 ||    184  |  | 192       204||     216|     |225       235        
                                               36|                      62A| 65A                         92||| ||                                           145|          160|   168|      186A  |          201|||     217A  222A                     
                                                38                       62B                              94|| ||                                            147           162    177         188A           204||                                    
                                                                                                           95| ||                                                                                             205|                                    
                                                                                                            98 ||                                                                                              208                                    
                                                                                                             99A|                                                                                                                                     
                                                                                                              99B                                                                                                                                     

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric/Biological Unit

(-) CATH Domains  (1, 4)

Asymmetric/Biological Unit
(-)
Class: Mainly Beta (13760)
1a1h1bA01A:16-27,A:121-232
1b1h1bB01B:16-27,B:121-232
1c1h1bA02A:28-120,A:233-243
1d1h1bB02B:28-120,B:233-243

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 1H1B)

(-) Gene Ontology  (40, 40)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,B   (ELNE_HUMAN | P08246)
molecular function
    GO:0001106    RNA polymerase II transcription corepressor activity    Interacting selectively and non-covalently with an RNA polymerase II repressing transcription factor and also with the RNA polymerase II basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
    GO:0019955    cytokine binding    Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
    GO:0004175    endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0002020    protease binding    Interacting selectively and non-covalently with any protease or peptidase.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0008236    serine-type peptidase activity    Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
    GO:0002438    acute inflammatory response to antigenic stimulus    An acute inflammatory response to an antigenic stimulus. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
    GO:0006874    cellular calcium ion homeostasis    Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.
    GO:0042742    defense response to bacterium    Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
    GO:0050832    defense response to fungus    Reactions triggered in response to the presence of a fungus that act to protect the cell or organism.
    GO:0022617    extracellular matrix disassembly    A process that results in the breakdown of the extracellular matrix.
    GO:0050900    leukocyte migration    The movement of a leukocyte within or between different tissues and organs of the body.
    GO:0045079    negative regulation of chemokine biosynthetic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.
    GO:0050922    negative regulation of chemotaxis    Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
    GO:0044130    negative regulation of growth of symbiont in host    Any process in which the symbiont stops, prevents or reduces its increase in size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction.
    GO:0050728    negative regulation of inflammatory response    Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
    GO:0045415    negative regulation of interleukin-8 biosynthetic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
    GO:0000122    negative regulation of transcription from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0070947    neutrophil mediated killing of fungus    The directed killing of a fungal cell by a neutrophil.
    GO:0006909    phagocytosis    An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0050778    positive regulation of immune response    Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
    GO:0045416    positive regulation of interleukin-8 biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
    GO:0048661    positive regulation of smooth muscle cell proliferation    Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
    GO:0030163    protein catabolic process    The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0009411    response to UV    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0001878    response to yeast    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a yeast species.
cellular component
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0030141    secretory granule    A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
    GO:0017053    transcriptional repressor complex    A protein complex that possesses activity that prevents or downregulates transcription.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    151  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 1h1b)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1h1b
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ELNE_HUMAN | P08246
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.21.37
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  162800
    Disease InformationOMIM
  202700
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ELNE_HUMAN | P08246
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ELNE_HUMAN | P082461b0f 1hne 1ppf 1ppg 2rg3 2z7f 3q76 3q77 4nzl 4wvp 5a09 5a0a 5a0b 5a0c 5a8x 5a8y 5a8z 5abw

(-) Related Entries Specified in the PDB File

1b0f CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146
1hne HUMAN NEUTROPHIL ELASTASE (HNE) (ALSO REFERRED TO AS HUMAN LEUCOCYTE ELASTASE (HLE)) COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALA CHLOROMETHYL KETONE (MSACK)
1ppf HUMAN LEUKOCYTE ELASTASE (HLE) (NEUTROPHIL ELASTASE (HNE)) COMPLEX WITH THE THIRD DOMAIN OF TURKEY OVOMUCOID INHIBITOR (OMTKY3)
1ppg HUMAN LEUKOCYTE ELASTASE (HLE) COMPLEX WITH MEO-SUCCINYL-ALA-ALA-PRO-VAL CHLOROMETHYLACETONE